Post by Dana-Farber Cancer Institute

This weekend, our researchers will present more than 50 studies at the American Association for Cancer Research (AACR) Annual Meeting in San Diego. Our select presentations include a promising clinical trial chemotherapy and RAS inhibitor combination for pancreatic patients, new research on mapping the tumor microbiome using the presence of microorganisms and encouraging results from a clinical trial for older patients with multiple myeloma precursor conditions. Learn more about our #AACR26 highlights here: https://bit.ly/41GQR4I